CD8A and neoplasm: For example, by blocking the PD-1 signaling receptor, the tumor-specific CD8+ T lymphocytes in the tumor microenvironment (TME) restore cytotoxicity, thereby inhibiting tumor immune escape ability and controlling the disease.